tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Appili Therapeutics to Showcase Biodefense Innovations at BARDA Symposium
PremiumCompany AnnouncementsAppili Therapeutics to Showcase Biodefense Innovations at BARDA Symposium
4M ago
Appili Therapeutics Secures $40 Million Contract for Fungal Vaccine Development
Premium
Company Announcements
Appili Therapeutics Secures $40 Million Contract for Fungal Vaccine Development
5M ago
Appili Therapeutics, Vitalix awarded up to $40M contract from NIAID
Premium
The Fly
Appili Therapeutics, Vitalix awarded up to $40M contract from NIAID
5M ago
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
PremiumThe FlyAppili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
6M ago
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
Premium
Company Announcements
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
6M ago
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
Premium
Company Announcements
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
8M ago
Appili Therapeutics publishes manuscript on emergency response to tularemia
PremiumThe FlyAppili Therapeutics publishes manuscript on emergency response to tularemia
10M ago
Appili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
Premium
Company Announcements
Appili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
10M ago
Appili Therapeutics granted new patents for LIKMEZ
Premium
The Fly
Appili Therapeutics granted new patents for LIKMEZ
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100